"To address the issue of price negotiation mechanisms for patented drugs, an Inter-ministerial Committee of Joint Secretaries has been set up ... to suggest ways and means to fix the prices of patented drugs in the country," Minister of Chemicals and Fertilisers Hansraj Gangaram Ahir said in a written reply to the Lok Sabha.
The minister was replying to a question whether the government proposes to regulate the prices of patented drugs in the country.
When asked if drug manufacturers from some countries, including the US, have expressed displeasure over the issue of being denied grant of patent for certain drugs for which Indian companies are producing generic drugs, Ahir said: "No, Madam".
'Modi must resist US pressure on drug patents'
Time for Indian pharma cos to change strategies
Policy tweaks in US shift Indian pharma's focus
Big Pharma still betting on 'messed up' Indian drugs market
All you need to know about Modi's new ministers